Advanced search
Publication Cover
Molecular and Cellular Biology Volume 32, 2012 - Issue 8
Submit an article Journal homepage
85
Views
137
CrossRef citations to date
0
Altmetric
Article

PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function

Jianglin Maa Department of Radiation Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
,
Hong Caia Department of Radiation Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
,
Tongde Wub Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA
,
Bijan Sobhianc Laboratoire de Virologie Moléculaire, Institut de Génétique Humaine, CNRS UPR1142, Montpellier, France
,
Yanying Huoa Department of Radiation Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
,
Allen Alcivara Department of Radiation Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
,
Monal Mehtad Department of Pharmacology and The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
,
Ka Lung Cheunge Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA
,
Shridar Ganesanf Department of Medicine and The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
,
Ah-Ng Tony Konge Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA
,
Donna D. Zhangb Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA
&
Bing Xiaa Department of Radiation Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USACorrespondence[email protected]
 show all
Pages 1506-1517 | Received 12 Sep 2011, Accepted 30 Jan 2012, Published online: 20 Mar 2023

Citations (137)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Sara Matić, Ivana Kekez, Marko Tomin, Ferenc Bogár, Filip Šupljika, Saša Kazazić, Maja Hanić, Shalinee Jha, Hrvoje Brkić, Benjamin Bourgeois, Tobias Madl, Karl Gruber, Peter Macheroux, Dubravka Matković-Čalogović, Mihaela Matovina & Sanja Tomić. (2021) Binding of dipeptidyl peptidase III to the oxidative stress cell sensor Kelch-like ECH-associated protein 1 is a two-step process. Journal of Biomolecular Structure and Dynamics 39:18, pages 6870-6881.
Read now
Qianlei Yang, Hanyi Deng, Haixuan Xia, Mengchuan Xu, Guotao Pan, Jiayuan Mao, Shasha Tao, Kenzo Yamanaka & Yan An. (2020) High NF-E2-related factor 2 expression predicts poor prognosis in patients with lung cancer: a meta-analysis of cohort studies. Free Radical Research 54:11-12, pages 790-798.
Read now
E. W. Cloer, P. F. Siesser, E. M. Cousins, D. Goldfarb, D. D. Mowrey, J. S. Harrison, S. J. Weir, N. V. Dokholyan & M. B. Major. (2018) p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2. Molecular and Cellular Biology 38:22.
Read now
Melissa C Southey, Zhi L Teo & Ingrid Winship. (2013) PALB2 and breast cancer: ready for clinical translation!. The Application of Clinical Genetics 6, pages 43-52.
Read now

Articles from other publishers (133)

Osman N. Kanwugu & Tatiana V. Glukhareva. (2023) Activation of Nrf2 pathway as a protective mechanism against oxidative stress-induced diseases: Potential of astaxanthin. Archives of Biochemistry and Biophysics 741, pages 109601.
Crossref
Ayan K. Ghosh, Yu-Pin Su, Michael Forman, Robert F. Keyes, Brian C. Smith, Xin Hu, Marc Ferrer & Ravit Arav-Boger. (2023) Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control. Journal of Virology 97:4.
Crossref
Ibolya Czegle, Chelsea Huang, Priscilla Geraldine Soria, Dylan Wesley Purkiss, Andrea Shields & Edina Amalia Wappler-Guzzetta. (2023) The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies. Life 13:4, pages 996.
Crossref
Yunjiang Zhou, Yaxin Chen, Yongwei Shi, Leyin Wu, Yingying Tan, Tao Li, Yigang Chen, Jiazeng Xia & Rong Hu. (2023) FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway. Journal of Clinical Investigation 133:3.
Crossref
Chuanlin Wang, Pengning Gao, Jiali Xu, Shanling Liu, Wenda Tian, Jiayu Liu & Lan Zhou. (2022) Natural phytochemicals prevent side effects in BRCA-mutated ovarian cancer and PARP inhibitor treatment. Frontiers in Pharmacology 13.
Crossref
Matthew Dodson, Aryatara Shakya, Annadurai Anandhan, Jinjing Chen, Joe G.N. Garcia & Donna D. Zhang. (2022) NRF2 and Diabetes: The Good, the Bad, and the Complex. Diabetes 71:12, pages 2463-2476.
Crossref
Vy Ngo & Martin L. Duennwald. (2022) Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease. Antioxidants 11:12, pages 2345.
Crossref
Mohammad Zubair Baba, S. Gomathy & Umair Wahedi. (2022) Role of Nrf2 Pathway Activation in Neurological Disorder: A Brief Review. Journal of Pharmacology and Pharmacotherapeutics 13:3, pages 229-238.
Crossref
Arun Jyothidasan, Sini Sunny, Saravanakumar Murugesan, Justin M. Quiles, Anil Kumar Challa, Brian Dalley, Senthil Kumar Cinghu, Vivek Nanda & Namakkal-Soorappan Rajasekaran. (2022) Transgenic Expression of Nrf2 Induces a Pro-Reductive Stress and Adaptive Cardiac Remodeling in the Mouse. Genes 13:9, pages 1514.
Crossref
Emiliano Panieri, Sónia A. Pinho, Gonçalo J. M. Afonso, Paulo J. Oliveira, Teresa Cunha-Oliveira & Luciano Saso. (2022) NRF2 and Mitochondrial Function in Cancer and Cancer Stem Cells. Cells 11:15, pages 2401.
Crossref
Shijie Wu, Lina Qi, Huihui Chen, Kun Zhang, Jiapan He, Xianan Guo, Lu Shen, Yunxiang Zhou, Xi Zhong, Shu Zheng, Jiaojiao Zhou & Yiding Chen. (2022) Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. npj Breast Cancer 8:1.
Crossref
Camilla Wolowczyk, Ulrike Neckmann, Miriam Ragle Aure, Martina Hall, Bjarne Johannessen, Sen Zhao, Rolf I. Skotheim, Sonja B. Andersen, Rosalie Zwiggelaar, Tonje S. Steigedal, Ole Christian Lingjærde, Kristine Kleivi Sahlberg, Eivind Almaas & Geir Bjørkøy. (2022) NRF2 drives an oxidative stress response predictive of breast cancer. Free Radical Biology and Medicine 184, pages 170-184.
Crossref
Yanying Huo, Akshada Sawant, Yongmei Tan, Amar H Mahdi, Tao Li, Hui Ma, Vrushank Bhatt, Run Yan, Jake Coleman, Cheryl F Dreyfus, Jessie Yanxiang Guo, M. Maral Mouradian, Eileen White & Bing Xia. (2022) Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration. PLOS Genetics 18:4, pages e1010138.
Crossref
Annina Bindschedler, Jacqueline Schmuckli-Maurer, Rahel Wacker, Nicolas Kramer, Ruth Rehmann, Reto Caldelari & Volker T. Heussler. (2022) Plasmodium berghei-Mediated NRF2 Activation in Infected Hepatocytes Enhances Parasite Survival. Cellular Microbiology 2022, pages 1-17.
Crossref
Ray Pillai, Makiko Hayashi, Anastasia-Maria Zavitsanou & Thales Papagiannakopoulos. (2022) NRF2: KEAPing Tumors Protected. Cancer Discovery 12:3, pages 625-643.
Crossref
Alexey V. Ulasov, Andrey A. Rosenkranz, Georgii P. Georgiev & Alexander S. Sobolev. (2022) Nrf2/Keap1/ARE signaling: Towards specific regulation. Life Sciences 291, pages 120111.
Crossref
Stephanie M. Boas, Kathlene L. Joyce & Rita M. Cowell. (2021) The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention. Antioxidants 11:1, pages 8.
Crossref
Silvia Bono, Marco Feligioni & Massimo Corbo. (2021) Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy. Molecular Neurodegeneration 16:1.
Crossref
Cody J. Schmidlin, Aryatara Shakya, Matthew Dodson, Eli Chapman & Donna D. Zhang. (2021) The intricacies of NRF2 regulation in cancer. Seminars in Cancer Biology 76, pages 110-119.
Crossref
Zhihua Kang, Pan Fu, Allen L. Alcivar, Haiqing Fu, Christophe Redon, Tzeh Keong Foo, Yamei Zuo, Caiyong Ye, Ryan Baxley, Advaitha Madireddy, Remi Buisson, Anja-Katrin Bielinsky, Lee Zou, Zhiyuan Shen, Mirit I. Aladjem & Bing Xia. (2021) BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage. Nature Communications 12:1.
Crossref
Chorlada Paiboonrungruang, Emily Simpson, Zhaohui Xiong, Caizhi Huang, Jianying Li, Yahui Li & Xiaoxin Chen. (2021) Development of targeted therapy of NRF2high esophageal squamous cell carcinoma. Cellular Signalling 86, pages 110105.
Crossref
Xavier Renaudin, Miyoung Lee, Mona Shehata, Eva-Maria Surmann & Ashok R. Venkitaraman. (2021) BRCA2 deficiency reveals that oxidative stress impairs RNaseH1 function to cripple mitochondrial DNA maintenance. Cell Reports 36:5, pages 109478.
Crossref
Bingbing Dai, Jithesh J. Augustine, Ya’an Kang, David Roife, Xinqun Li, Jenying Deng, Lin Tan, Leona A. Rusling, John N. Weinstein, Philip L. Lorenzi, Michael P. Kim & Jason B. Fleming. (2021) Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway. Cell Death & Disease 12:7.
Crossref
Perinur BOZAYKUT EKER. (2021) Transcriptomics analysis of Nrf2 regulators in cancer resistant and long-lived naked mole-rats. Acibadem Universitesi Saglik Bilimleri Dergisi 12:3.
Crossref
Sarah E. Brnich, Eyla Cristina Arteaga, Yueting Wang, Xianming Tan & Jonathan S. Berg. (2021) A Validated Functional Analysis of Partner and Localizer of BRCA2 Missense Variants for Use in Clinical Variant Interpretation. The Journal of Molecular Diagnostics 23:7, pages 847-864.
Crossref
Dunfa Peng, Alexander Zaika, Jianwen Que & Wael El-Rifai. (2021) The antioxidant response in Barrett's tumorigenesis: A double-edged sword. Redox Biology 41, pages 101894.
Crossref
Yanying Huo, Pier Selenica, Amar H. Mahdi, Fresia Pareja, Kelly Kyker-Snowman, Ying Chen, Rahul Kumar, Arnaud Da Cruz Paula, Thais Basili, David N. Brown, Xin Pei, Nadeem Riaz, Yongmei Tan, Yu-Xiu Huang, Tao Li, Nicola J. Barnard, Jorge S. Reis-Filho, Britta Weigelt & Bing Xia. (2021) Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development. npj Breast Cancer 7:1.
Crossref
Pelin Telkoparan-Akillilar, Emiliano Panieri, Dilek Cevik, Sibel Suzen & Luciano Saso. (2021) Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer. Molecules 26:5, pages 1417.
Crossref
Shanshan Zhou, Jingpeng Jin, Jiqun Wang, Zhiguo Zhang, Shanshan Huang, Yang Zheng & Lu Cai. (2021) Effects of Breast Cancer Genes 1 and 2 on Cardiovascular Diseases. Current Problems in Cardiology 46:3, pages 100421.
Crossref
Vinee Purohit, Lidong Wang, Huibin Yang, Jiufeng Li, Gina M. Ney, Erica R. Gumkowski, Akash J. Vaidya, Annie Wang, Amit Bhardwaj, Ende Zhao, Igor Dolgalev, Andrea Zamperone, Ethan V. Abel, Marina Pasca Di Magliano, Howard C. Crawford, Daniel Diolaiti, Thales Y. Papagiannakopoulos, Costas A. Lyssiotis & Diane M. Simeone. (2021) ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer. Genes & Development 35:3-4, pages 218-233.
Crossref
Yue Zhang, Jung‐Young Park, Fan Zhang, Sara H. Olson, Irene Orlow, Yirong Li, Robert C. Kurtz, Marc Ladanyi, Jie Chen, Amanda E. Toland, Liying Zhang & Paul R. Andreassen. (2020) The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response. Human Mutation 42:2, pages 150-163.
Crossref
Xavier Renaudin. 2021. Chromatin and Genomic Instability in Cancer. Chromatin and Genomic Instability in Cancer 139 161 .
Keiko Taguchi & Masayuki Yamamoto. (2020) The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment. Cancers 13:1, pages 46.
Crossref
Katarína SmolkováEdit MikóTünde KovácsAlberto Leguina-RuzziAdrienn SiposPéter Bai. (2020) Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism. Antioxidants & Redox Signaling 33:13, pages 966-997.
Crossref
Janine M. DeBlasi & Gina M. DeNicola. (2020) Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer. Cancers 12:10, pages 3023.
Crossref
Tharindu L. Suraweera, H. P. Vasantha Rupasinghe, Graham Dellaire & Zhaolin Xu. (2020) Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management?. Antioxidants 9:10, pages 973.
Crossref
Wei Wei, Ning Ma, Xiaoye Fan, Qinlei Yu & Xinxin Ci. (2020) The role of Nrf2 in acute kidney injury: Novel molecular mechanisms and therapeutic approaches. Free Radical Biology and Medicine 158, pages 1-12.
Crossref
Rick A. C. M. Boonen, Maaike P. G. Vreeswijk & Haico van Attikum. (2020) Functional Characterization of PALB2 Variants of Uncertain Significance: Toward Cancer Risk and Therapy Response Prediction. Frontiers in Molecular Biosciences 7.
Crossref
Aleksandra Kopacz, Damian Kloska, Henry Jay Forman, Alicja Jozkowicz & Anna Grochot-Przeczek. (2020) Beyond repression of Nrf2: An update on Keap1. Free Radical Biology and Medicine 157, pages 63-74.
Crossref
Yong Zhang, Zeyu Shi, Yujun Zhou, Qiong Xiao, Hongyue Wang & Ying Peng. (2020) Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction. Journal of Medicinal Chemistry 63:15, pages 7986-8002.
Crossref
Feng He, Xiaoli Ru & Tao Wen. (2020) NRF2, a Transcription Factor for Stress Response and Beyond. International Journal of Molecular Sciences 21:13, pages 4777.
Crossref
Jong-Su Kang, Le Ba Nam, Ok-Kyung Yoo & Young-Sam Keum. (2020) Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer. Biochemical Pharmacology 177, pages 114002.
Crossref
Feng He, Laura Antonucci & Michael Karin. (2020) NRF2 as a regulator of cell metabolism and inflammation in cancer. Carcinogenesis 41:4, pages 405-416.
Crossref
Mariacarmela Santarpia, Andrés Aguilar, Imane Chaib, Andrés Felipe Cardona, Sara Fancelli, Fernando Laguia, Jillian Wilhelmina Paulina Bracht, Peng Cao, Miguel Angel Molina-Vila, Niki Karachaliou & Rafael Rosell. (2020) Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies. Cancers 12:6, pages 1475.
Crossref
Zheng‐Hua Wan, Tian‐Yi Jiang, Yuan‐Yuan Shi, Yu‐Fei Pan, Yun‐Kai Lin, Yun‐Han Ma, Chun Yang, Xiao‐Fan Feng, Li‐Feng Huang, Xiao‐Ni Kong, Zhi‐Wen Ding, Ye‐Xiong Tan, Li‐Wei Dong & Hong‐Yang Wang. (2020) RPB5‐Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding. Hepatology 71:6, pages 2005-2022.
Crossref
Warren L. WuThales Papagiannakopoulos. (2020) The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer. Annual Review of Cancer Biology 4:1, pages 413-435.
Crossref
Somaira Nowsheen, Min Deng & Zhenkun Lou. (2019) Ubiquitin and the DNA double-strand break repair pathway. Genome Instability & Disease 1:2, pages 69-80.
Crossref
Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun & Yiding Chen. (2020) Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management. Frontiers in Oncology 10.
Crossref
Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, Ghazaleh Amjad, Mohammad Reza Ebadi & Ladan Younesi. (2019) Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms. Journal of Hematology & Oncology 12:1.
Crossref
Jiang-Jiang Qin, Xiang-Dong Cheng, Jia Zhang & Wei-Dong Zhang. (2019) Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. Cell Communication and Signaling 17:1.
Crossref
Le Ba Nam & Young-Sam Keum. (2019) Binding partners of NRF2: Functions and regulatory mechanisms. Archives of Biochemistry and Biophysics 678, pages 108184.
Crossref
Amélie Rodrigue, Guillaume Margaillan, Thiago Torres Gomes, Yan Coulombe, Gemma Montalban, Simone da Costa e Silva Carvalho, Larissa Milano, Mandy Ducy, Giuliana De-Gregoriis, Graham Dellaire, Wilson Araújo da Silva Jr, Alvaro N Monteiro, Marcelo A Carvalho, Jacques Simard & Jean-Yves Masson. (2019) A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor. Nucleic Acids Research 47:20, pages 10662-10677.
Crossref
Shanshan Liu, Shengmei Xu, Renrong Wei, Zhizhong Cui, Xiaoyun Wu, Renxiong Wei, Li Xie, Yingye Zhou, Wenjuan Li & Weimin Chen. (2019) Keap1 Cystenine 151 as a Potential Target for Artemisitene-Induced Nrf2 Activation. BioMed Research International 2019, pages 1-8.
Crossref
Katerina Jerabkova & Izabela Sumara. (2019) Cullin 3, a cellular scripter of the non-proteolytic ubiquitin code. Seminars in Cell & Developmental Biology 93, pages 100-110.
Crossref
Lili Ji, Rui Zhang, Jie Chen, Qun Xue, Nadeem Moghal & Ming-Sound Tsao. (2019) PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC. Scientific Reports 9:1.
Crossref
Vinee Purohit, Diane M. Simeone & Costas A. Lyssiotis. (2019) Metabolic Regulation of Redox Balance in Cancer. Cancers 11:7, pages 955.
Crossref
Kai-Chun Cheng, Ruey-Jen Lin, Jing-Yan Cheng, Sheng-Hung Wang, Jyh-Cherng Yu, Jen-Chine Wu, Yuh-Jin Liang, Huan-Ming Hsu, John Yu & Alice L. Yu. (2019) FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding. EBioMedicine 45, pages 25-38.
Crossref
Xiao-Lei Zhou, Chong-Yue Zhu, Zhi-Gang Wu, Xin Guo & Wei Zou. (2019) The oncoprotein HBXIP competitively binds KEAP1 to activate NRF2 and enhance breast cancer cell growth and metastasis. Oncogene 38:21, pages 4028-4046.
Crossref
Shijia Wu, Hong Lu & Yongheng Bai. (2019) Nrf2 in cancers: A double‐edged sword. Cancer Medicine 8:5, pages 2252-2267.
Crossref
Jaigeeth Deveryshetty, Thibaut Peterlini, Mikhail Ryzhikov, Nadine Brahiti, Graham Dellaire, Jean-Yves Masson & Sergey Korolev. (2019) Novel RNA and DNA strand exchange activity of the PALB2 DNA binding domain and its critical role for DNA repair in cells. eLife 8.
Crossref
Pelin Telkoparan-Akillilar, Sibel Suzen & Luciano Saso. (2019) Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs. International Journal of Molecular Sciences 20:8, pages 2025.
Crossref
Emiliano Panieri & Luciano Saso. (2019) Potential Applications of NRF2 Inhibitors in Cancer Therapy. Oxidative Medicine and Cellular Longevity 2019, pages 1-34.
Crossref
Li Tian, Yun Lu, Tao Yang, Zhengdong Deng, Lei Xu, Wei Yao, Chaoqun Ma, Xiangyu Li, Jian Zhang, Yan Liu & Jianming Wang. (2019) aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1. Redox Biology 22, pages 101149.
Crossref
Erica W. Cloer, Dennis Goldfarb, Travis P. Schrank, Bernard E. Weissman & Michael B. Major. (2019) NRF2 Activation in Cancer: From DNA to Protein. Cancer Research 79:5, pages 889-898.
Crossref
Srilatha Simhadri, Gabriele Vincelli, Yanying Huo, Sarah Misenko, Tzeh Keong Foo, Johanna Ahlskog, Claus S. Sørensen, Gregory G. Oakley, Shridar Ganesan, Samuel F. Bunting & Bing Xia. (2018) PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response. Oncogene 38:10, pages 1585-1596.
Crossref
Mandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, Anahita Lashgari, Yuandi Gao, Nadine Brahiti, Amélie Rodrigue, Guillaume Margaillan, Marie-Christine Caron, Jacques Côté, Jacques Simard & Jean-Yves Masson. (2019) The Tumor Suppressor PALB2: Inside Out. Trends in Biochemical Sciences 44:3, pages 226-240.
Crossref
Rafael Franco, Gemma Navarro & Eva Martínez-Pinilla. (2019) Antioxidant Defense Mechanisms in Erythrocytes and in the Central Nervous System. Antioxidants 8:2, pages 46.
Crossref
Jennifer Yinuo Cao, Aunoy Poddar, Leslie Magtanong, Jennifer H. Lumb, Trevor R. Mileur, Michael A. Reid, Cole M. Dovey, Jin Wang, Jason W. Locasale, Everett Stone, Susan P.C. Cole, Jan E. Carette & Scott J. Dixon. (2019) A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity. Cell Reports 26:6, pages 1544-1556.e8.
Crossref
Nathalie van den Tempel, Alex Zelensky, Hanny Odijk, Charlie Laffeber, Christine Schmidt, Inger Brandsma, Jeroen Demmers, Przemek Krawczyk & Roland Kanaar. (2019) On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation. Cancers 11:1, pages 97.
Crossref
Larissa Staurengo-Ferrari, Stephanie Badaro-Garcia, Miriam S. N. Hohmann, Marília F. Manchope, Tiago H. Zaninelli, Rubia Casagrande & Waldiceu A. VerriJr.Jr.. (2019) Contribution of Nrf2 Modulation to the Mechanism of Action of Analgesic and Anti-inflammatory Drugs in Pre-clinical and Clinical Stages. Frontiers in Pharmacology 9.
Crossref
Junsheng Fu, Zhaohui Xiong, Caizhi Huang, Jing Li, Wenjun Yang, Yuning Han, Chorlada Paiboonrungruan, Michael B. Major, Ke-Neng Chen, Xiaozheng Kang & Xiaoxin Chen. (2019) Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus. Journal of Biological Chemistry 294:1, pages 327-340.
Crossref
Sae Bom LeeBrianna N. SellersGina M. DeNicola. (2018) The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism. Antioxidants & Redox Signaling 29:17, pages 1774-1791.
Crossref
Claudia TonelliIok In Christine ChioDavid A. Tuveson. (2018) Transcriptional Regulation by Nrf2. Antioxidants & Redox Signaling 29:17, pages 1727-1745.
Crossref
Nele Tamberg, Siret Tahk, Sandra Koit, Kersti Kristjuhan, Sergo Kasvandik, Arnold Kristjuhan & Ivar Ilves. (2018) Keap1–MCM3 interaction is a potential coordinator of molecular machineries of antioxidant response and genomic DNA replication in metazoa. Scientific Reports 8:1.
Crossref
Carlos Alfredo Silva-Islas & Perla D. Maldonado. (2018) Canonical and non-canonical mechanisms of Nrf2 activation. Pharmacological Research 134, pages 92-99.
Crossref
Amar Hekmat Mahdi, Yanying Huo, Yongmei Tan, Srilatha Simhadri, Gabriele Vincelli, Jie Gao, Shridar Ganesan & Bing Xia. (2018) Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1–PALB2 Interaction. Cancer Research 78:14, pages 3969-3981.
Crossref
Montserrat Rojo de la Vega, Eli Chapman & Donna D. Zhang. (2018) NRF2 and the Hallmarks of Cancer. Cancer Cell 34:1, pages 21-43.
Crossref
Mikko Karttunen, Wing-Yiu Choy & Elio A. Cino. (2018) Prediction of Binding Energy of Keap1 Interaction Motifs in the Nrf2 Antioxidant Pathway and Design of Potential High-Affinity Peptides. The Journal of Physical Chemistry B 122:22, pages 5851-5859.
Crossref
Jingze Zhang, Qinghua Jiao, Li Kong, Jing Yu, Aiju Fang, Minghuan Li & Jinming Yu. (2018) Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy. Thoracic Cancer 9:6, pages 726-735.
Crossref
Byung-Jin Jung, Hwan-Sic Yoo, Sooyoung Shin, Young-Joon Park & Sang-Min Jeon. (2018) Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities. Biomolecules & Therapeutics 26:1, pages 57-68.
Crossref
M. Rojo de la Vega, M. Dodson & D.D. Zhang. 2018. Comprehensive Toxicology. Comprehensive Toxicology 337 351 .
Rasha SabounyErik FraunbergerMichèle GeoffrionAndy Cheuk-Him NgStephen D. BairdRobert A. ScreatonRoss MilneHeidi M. McBrideTimothy E. Shutt. (2017) The Keap1–Nrf2 Stress Response Pathway Promotes Mitochondrial Hyperfusion Through Degradation of the Mitochondrial Fission Protein Drp1. Antioxidants & Redox Signaling 27:18, pages 1447-1459.
Crossref
John D. Hayes & Albena T. Dinkova-Kostova. (2017) Oncogene-Stimulated Congestion at the KEAP1 Stress Signaling Hub Allows Bypass of NRF2 and Induction of NRF2-Target Genes that Promote Tumor Survival. Cancer Cell 32:5, pages 539-541.
Crossref
Q Wang, J Ma, Y Lu, S Zhang, J Huang, J Chen, J-X Bei, K Yang, G Wu, K Huang, J Chen & S Xu. (2017) CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells. Oncogene 36:37, pages 5321-5330.
Crossref
Thales Nepomuceno, Giuliana De Gregoriis, Francisco M. Bastos de Oliveira, Guilherme Suarez-Kurtz, Alvaro Monteiro & Marcelo Carvalho. (2017) The Role of PALB2 in the DNA Damage Response and Cancer Predisposition. International Journal of Molecular Sciences 18:9, pages 1886.
Crossref
Kevin Lu, Allen L. Alcivar, Jianglin Ma, Tzeh Keong Foo, Susan Zywea, Amar Mahdi, Yanying Huo, Thomas W. Kensler, Michael L. Gatza & Bing Xia. (2017) NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress–Induced DPP3–KEAP1 Interaction. Cancer Research 77:11, pages 2881-2892.
Crossref
Wenyan Gong, Jie Li, Zhiquan Chen, Junying Huang, Qiuhong Chen, Weibin Cai, Peiqing Liu & Heqing Huang. (2017) Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating CKIP-1 to resist HG-induced up-regulation of FN and ICAM-1 in GMCs and diabetic mice kidneys. Free Radical Biology and Medicine 106, pages 393-405.
Crossref
Rachel W Anantha, Srilatha Simhadri, Tzeh Keong Foo, Susanna Miao, Jingmei Liu, Zhiyuan Shen, Shridar Ganesan & Bing Xia. (2017) Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. eLife 6.
Crossref
Joris Pauty, Anthony M. Couturier, Amélie Rodrigue, Marie-Christine Caron, Yan Coulombe, Graham Dellaire & Jean-Yves Masson. (2017) Cancer-causing mutations in the tumor suppressor PALB2 reveal a novel cancer mechanism using a hidden nuclear export signal in the WD40 repeat motif. Nucleic Acids Research 45:5, pages 2644-2657.
Crossref
Yuji Fuse & Makoto Kobayashi. (2017) Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time. Molecules 22:3, pages 436.
Crossref
Virve Sihvola & Anna-Liisa Levonen. (2017) Keap1 as the redox sensor of the antioxidant response. Archives of Biochemistry and Biophysics 617, pages 94-100.
Crossref
Rémi Buisson, Joshi Niraj, Amélie Rodrigue, Chu Kwen Ho, Johannes Kreuzer, Tzeh Keong Foo, Emilie J.-L. Hardy, Graham Dellaire, Wilhelm Haas, Bing Xia, Jean-Yves Masson & Lee Zou. (2017) Coupling of Homologous Recombination and the Checkpoint by ATR. Molecular Cell 65:2, pages 336-346.
Crossref
Lorenza P. Ferretti, Sarah-Felicitas Himmels, Anika Trenner, Christina Walker, Christine von Aesch, Aline Eggenschwiler, Olga Murina, Radoslav I. Enchev, Matthias Peter, Raimundo Freire, Antonio Porro & Alessandro A. Sartori. (2016) Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-tune DNA-end resection. Nature Communications 7:1.
Crossref
Koji Taniguchi, Shinichiro Yamachika, Feng He & Michael Karin. (2016) p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Letters 590:15, pages 2375-2397.
Crossref
Weimin Chen, Shanshan Li, Jinwei Li, Wen Zhou, Shouhai Wu, Shengmei Xu, Ke Cui, Donna D. Zhang & Bo Liu. (2016) Artemisitene activates the Nrf2‐dependent antioxidant response and protects against bleomycin‐induced lung injury. The FASEB Journal 30:7, pages 2500-2510.
Crossref
Elena V. Knatko, Maureen Higgins, Jed W. Fahey & Albena T. Dinkova-Kostova. (2016) Loss of Nrf2 abrogates the protective effect of Keap1 downregulation in a preclinical model of cutaneous squamous cell carcinoma. Scientific Reports 6:1.
Crossref
Chun Yang, Ye-xiong Tan, Guang-zhen Yang, Jian Zhang, Yu-fei Pan, Chen Liu, Jing Fu, Yao Chen, Zhi-wen Ding, Li-wei Dong & Hong-yang Wang. (2016) Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma. Journal of Experimental Medicine 213:5, pages 859-875.
Crossref
Montserrat Rojo de la Vega, Matthew Dodson, Christine Gross, Heidi M. Mansour, R. Clark Lantz, Eli Chapman, Ting Wang, Stephen M. Black, Joe G. N. Garcia & Donna D. Zhang. (2016) Role of Nrf2 and Autophagy in Acute Lung Injury. Current Pharmacology Reports 2:2, pages 91-101.
Crossref
Fangyuan Li, Jiang Zhou, Ming Xu & Gu Yuan. (2016) Investigation on the formation, conversion and bioactivity of a G-quadruplex structure in the PALB2 gene. International Journal of Biological Macromolecules 83, pages 242-248.
Crossref
Trang Nhu Do, Wing-Yiu Choy & Mikko Karttunen. (2015) Binding of Disordered Peptides to Kelch: Insights from Enhanced Sampling Simulations. Journal of Chemical Theory and Computation 12:1, pages 395-404.
Crossref
A. L. Furfaro, N. Traverso, C. Domenicotti, S. Piras, L. Moretta, U. M. Marinari, M. A. Pronzato & M. Nitti. (2016) The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance. Oxidative Medicine and Cellular Longevity 2016, pages 1-14.
Crossref
Joel Isohookana, Kirsi-Maria Haapasaari, Ylermi Soini & Peeter Karihtala. (2015) Keap1 expression has independent prognostic value in pancreatic adenocarcinomas. Diagnostic Pathology 10:1.
Crossref
Alexandre Orthwein, Sylvie M. Noordermeer, Marcus D. Wilson, Sébastien Landry, Radoslav I. Enchev, Alana Sherker, Meagan Munro, Jordan Pinder, Jayme Salsman, Graham Dellaire, Bing Xia, Matthias Peter & Daniel Durocher. (2015) A mechanism for the suppression of homologous recombination in G1 cells. Nature 528:7582, pages 422-426.
Crossref
Yingying Guo, Wanjuan Feng, Shirley M.H. Sy & Michael S.Y. Huen. (2015) ATM-dependent Phosphorylation of the Fanconi Anemia Protein PALB2 Promotes the DNA Damage Response. Journal of Biological Chemistry 290:46, pages 27545-27556.
Crossref
Delinda A. Johnson & Jeffrey A. Johnson. (2015) Nrf2—a therapeutic target for the treatment of neurodegenerative diseases. Free Radical Biology and Medicine 88, pages 253-267.
Crossref
H Y Chen, J Y Hu, T H Chen, Y C Lin, X Liu, M Y Lin, Y D Lang, Y Yen & R H Chen. (2015) KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination. Oncogene 34:40, pages 5141-5151.
Crossref
Hanna M. Leinonen, Emilia Kansanen, Petri Pölönen, Merja Heinäniemi & Anna-Liisa Levonen. (2015) Dysregulation of the Keap1–Nrf2 pathway in cancer. Biochemical Society Transactions 43:4, pages 645-649.
Crossref
Jaana M. Hartikainen, Maria Tengström, Robert Winqvist, Arja Jukkola-Vuorinen, Katri Pylkäs, Veli-Matti Kosma, Ylermi Soini & Arto Mannermaa. (2015) KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes . Clinical Cancer Research 21:7, pages 1591-1601.
Crossref
Halema Khan, Ryan C. Killoran, Anne Brickenden, Jingsong Fan, Daiwen Yang & Wing-Yiu Choy. (2015) Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1. Biochemical Journal 467:1, pages 141-151.
Crossref
Kaitlyn N. LewisEmily Wason, Yael H. EdreyDeborah M. Kristan, Eviatar Nevo & Rochelle Buffenstein. (2015) Regulation of Nrf2 signaling and longevity in naturally long-lived rodents. Proceedings of the National Academy of Sciences 112:12, pages 3722-3727.
Crossref
Kendra S. Plafker & Scott M. Plafker. (2015) The ubiquitin-conjugating enzyme UBE2E3 and its import receptor importin-11 regulate the localization and activity of the antioxidant transcription factor NRF2. Molecular Biology of the Cell 26:2, pages 327-338.
Crossref
Yong Weon Yi & Seunghoon Oh. (2014) Comparative analysis of NRF2-responsive gene expression in AcPC-1 pancreatic cancer cell line. Genes & Genomics 37:1, pages 97-109.
Crossref
Hyo Jin Kang, Yong Weon Yi, Young Bin Hong, Hee Jeong Kim, Young-Joo Jang, Yeon-Sun Seong & Insoo Bae. (2014) HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction. Scientific Reports 4:1.
Crossref
Liam Baird, Sam Swift, David Llères & Albena T. Dinkova-Kostova. (2014) Monitoring Keap1–Nrf2 interactions in single live cells. Biotechnology Advances 32:6, pages 1133-1144.
Crossref
Akhileshwar Namani, Yulong Li, Xiu Jun Wang & Xiuwen Tang. (2014) Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:9, pages 1875-1885.
Crossref
Srilatha Simhadri, Shaun Peterson, Dharm S. Patel, Yanying Huo, Hong Cai, Christian Bowman-Colin, Shoreh Miller, Thomas Ludwig, Shridar Ganesan, Mantu Bhaumik, Samuel F. Bunting, Maria Jasin & Bing Xia. (2014) Male Fertility Defect Associated with Disrupted BRCA1-PALB2 Interaction in Mice. Journal of Biological Chemistry 289:35, pages 24617-24629.
Crossref
Jung-Young Park, Fan Zhang & Paul R. Andreassen. (2014) PALB2: The hub of a network of tumor suppressors involved in DNA damage responses. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:1, pages 263-275.
Crossref
Young-Sam Keum & Bu Choi. (2014) Molecular and Chemical Regulation of the Keap1-Nrf2 Signaling Pathway. Molecules 19:7, pages 10074-10089.
Crossref
Joris Pauty, Amélie Rodrigue, Anthony Couturier, Rémi BuissonJean-Yves Masson. (2014) Exploring the roles of PALB2 at the crossroads of DNA repair and cancer. Biochemical Journal 460:3, pages 331-342.
Crossref
John D. Hayes & Albena T. Dinkova-Kostova. (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends in Biochemical Sciences 39:4, pages 199-218.
Crossref
Bridgid E. Hast, Erica W. Cloer, Dennis Goldfarb, Heng Li, Priscila F. Siesser, Feng Yan, Vonn Walter, Ning Zheng, D. Neil Hayes & Michael B. Major. (2014) Cancer-Derived Mutations in KEAP1 Impair NRF2 Degradation but not Ubiquitination. Cancer Research 74:3, pages 808-817.
Crossref
Suryakant K. Niture, Raju Khatri & Anil K. Jaiswal. (2014) Regulation of Nrf2—an update. Free Radical Biology and Medicine 66, pages 36-44.
Crossref
Hanna M. Leinonen, Emilia Kansanen, Petri Pölönen, Merja Heinäniemi & Anna-Liisa Levonen. 2014. Redox and Cancer Part A. Redox and Cancer Part A 281 320 .
Jeffrey R Marks. (2013) Refining the role of BRCA1 in combating oxidative stress. Breast Cancer Research 15:6.
Crossref
Jessie Yanxiang Guo, Bing Xia & Eileen White. (2013) Autophagy-Mediated Tumor Promotion. Cell 155:6, pages 1216-1219.
Crossref
Melba C. Jaramillo & Donna D. Zhang. (2013) The emerging role of the Nrf2–Keap1 signaling pathway in cancer. Genes & Development 27:20, pages 2179-2191.
Crossref
Elio Cino, Jingsong Fan, Daiwen Yang & Wing-Yiu Choy. (2012) 1H, 15N and 13C backbone resonance assignments of the Kelch domain of mouse Keap1. Biomolecular NMR Assignments 7:2, pages 149-153.
Crossref
Yanying Huo, Hong Cai, Irina Teplova, Christian Bowman-Colin, Guanghua Chen, Sandy Price, Nicola Barnard, Shridar Ganesan, Vassiliki Karantza, Eileen White & Bing Xia. (2013) Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2 -Associated Hereditary Breast Cancer . Cancer Discovery 3:8, pages 894-907.
Crossref
Elio A. Cino, Ryan C. Killoran, Mikko Karttunen & Wing-Yiu Choy. (2013) Binding of disordered proteins to a protein hub. Scientific Reports 3:1.
Crossref
Bridgid E. Hast, Dennis Goldfarb, Kathleen M. Mulvaney, Michael A. Hast, Priscila F. Siesser, Feng Yan, D. Neil Hayes & Michael B. Major. (2013) Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 Ubiquitination. Cancer Research 73:7, pages 2199-2210.
Crossref
Phillip Shelton & Anil K. Jaiswal. (2012) The transcription factor NF‐E2‐related Factor 2 (Nrf2): a protooncogene?. The FASEB Journal 27:2, pages 414-423.
Crossref
Suryakant K. Niture, Averell Gnatt & Anil K. Jaiswal. (2013) Oncogene PKCε controls INrf2:Nrf2 interaction in normal and cancer cells through INrf2 phosphorylation. Journal of Cell Science.
Crossref
Elio A. Cino, Wing-Yiu Choy & Mikko Karttunen. (2012) Comparison of Secondary Structure Formation Using 10 Different Force Fields in Microsecond Molecular Dynamics Simulations. Journal of Chemical Theory and Computation 8:8, pages 2725-2740.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.